Evidence map›Paper›PMID 38778384›Full record

ArticleBMC pharmacology & toxicology2024

Anti-pruritic effect of L-carnitine against chloroquine-induced pruritus mediated via nitric oxide pathway.

Kiran Seemab, Arif-Ullah Khan, Muhammad Imran Khan, Neelum Gul Qazi, Amber Mahmood Minhas, Fawad Ali

Abstract read
In one paragraph

Article in BMC pharmacology & toxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kiran Seemab *Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.
Arif-Ullah KhanRiphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan. arif.ullah@riphah.edu.pk.
Muhammad Imran KhanDepartment of Biomedical Science, Pak-Austria Fachhochule: Institute of Applied Science and Technology, Mang Haripur, KPK, Pakistan.
Neelum Gul Qazi *Department of Pharmacy, Iqra University, Islamabad, Pakistan. dr.nenogull@gmail.com.
Amber Mahmood MinhasRiphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.
Fawad AliDepartment of Pharmacy, Kohat University of Science and Technology, Kohat, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPruritus, or itching, is a distressing symptom associated with various dermatological and systemic diseases. L-carnitine (βeta hydroxy-γ-tri methyl amino-butyric acid), is a naturally occurring substance, it controls numerous physiological processes. The present research aims to identify L-carnitine for its anti-pruritic effect via nitric oxide-dependent mechanism.

methodsChloroquine-induced pruritus serves as an experimental model to investigate possible therapeutic interventions. In this study, we evaluated the efficacy of L-carnitine in combating oxidative stress, nitric oxide, and inflammatory cytokines in a chloroquine-induced pruritus model.

resultsL-carnitine treatment significantly reduced scratching behavior compared to the disease group (

conclusionThese findings highlight the therapeutic effects of L-carnitine in alleviating chloroquine-induced pruritus.

Indexed as

CarnitineChloroquineNitric OxideOxidative StressPruritusAnimalsAntipruriticsCyclooxygenase 2CytokinesMaleMiceSignal TransductionAntipruriticsCarnitineChloroquineCyclooxygenase 2CytokinesNitric OxideAnti-inflammatoryAnti-oxidantL-carnitineNitric oxidePruritus

Identifiers

PMID38778384
PMCPMC11110330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.